drugset / Trial / NCT00804895

Cluster Headache Cortivazol Injection (CHCI)

NCT00804895 ↗

Phase 2/3 Completed 43 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupTriple-blindTreatment

Summary

the aim of tis study is to demonstrate the efficacy of cortivazol injections at the level of the greater occipital nerve to diminish the frequency of cluster headache (episodic or chronic) attacks during an active period. Injections will be used in adjunct with oral verapamil.

Timeline

Start
2008-12
Primary completion
2009-10
Completion
2009-10

Outcome

Met primary endpoint

paper 20 of 21 patients who received cortivazol had a mean of two or fewer daily attacks after injections compared with 12 of 22 controls PMID 21903477 ↗

paper odds ratio 14·5, 95% CI 1·8-116·9; p=0·012 PMID 21903477 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject cortivazol Other / unclassified 3.75 mg Subcutaneous
Background Verapamil Other / unclassified — Oral